Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Prognosis after lead extraction in patients with cardiac implantable electronic devices infection: Comparison of lead-related infective endocarditis with pocket infection in a Japanese single-center experience.

Nishii N, Morimoto Y, Miyoshi A, Tsukuda S, Miyamoto M, Kawada S, Nakagawa K, Watanabe A, Nakamura K, Morita H, Morimatsu H, Kusano N, Kasahara S, Shoda M, Ito H.

J Arrhythm. 2019 Jun 28;35(4):654-663. doi: 10.1002/joa3.12164. eCollection 2019 Aug.

2.

A Low Critical Event Rate Despite a High Abnormal Event Rate in Patients with Cardiac Implantable Electric Devices Followed Up by Remote Monitoring.

Morimoto Y, Nishii N, Tsukuda S, Kawada S, Miyamoto M, Miyoshi A, Nakagawa K, Watanabe A, Nakamura K, Morita H, Ito H.

Intern Med. 2019 Aug 15;58(16):2333-2340. doi: 10.2169/internalmedicine.1905-18. Epub 2019 May 22.

3.

Proton transport properties of proton-conducting phosphate glasses at their glass transition temperatures.

Omata T, Yamaguchi T, Tsukuda S, Ishiyama T, Nishii J, Yamashita T, Kawazoe H.

Phys Chem Chem Phys. 2019 May 28;21(20):10744-10749. doi: 10.1039/c9cp01502g. Epub 2019 May 14.

PMID:
31086916
4.

Double-Circularly Connected Saloph-Belt Macrocycles Generated from a Bis-Armed Bifunctional Monomer.

Nakamura T, Tsukuda S, Nabeshima T.

J Am Chem Soc. 2019 Apr 24;141(16):6462-6467. doi: 10.1021/jacs.9b00171. Epub 2019 Apr 12.

PMID:
30958001
5.

Concept of Viral Inhibitors via NTCP.

Fukano K, Tsukuda S, Watashi K, Wakita T.

Semin Liver Dis. 2019 Feb;39(1):78-85. doi: 10.1055/s-0038-1676804. Epub 2019 Jan 17. Review.

PMID:
30809790
6.

Troglitazone Impedes the Oligomerization of Sodium Taurocholate Cotransporting Polypeptide and Entry of Hepatitis B Virus Into Hepatocytes.

Fukano K, Tsukuda S, Oshima M, Suzuki R, Aizaki H, Ohki M, Park SY, Muramatsu M, Wakita T, Sureau C, Ogasawara Y, Watashi K.

Front Microbiol. 2019 Jan 8;9:3257. doi: 10.3389/fmicb.2018.03257. eCollection 2018.

7.

A Single Adaptive Mutation in Sodium Taurocholate Cotransporting Polypeptide Induced by Hepadnaviruses Determines Virus Species Specificity.

Takeuchi JS, Fukano K, Iwamoto M, Tsukuda S, Suzuki R, Aizaki H, Muramatsu M, Wakita T, Sureau C, Watashi K.

J Virol. 2019 Feb 19;93(5). pii: e01432-18. doi: 10.1128/JVI.01432-18. Print 2019 Mar 1.

8.

A new approach for implantation of a cardiac resynchronization therapy-defibrillator in a patient with bilateral pectoral neurostimulation devices.

Tsukuda S, Nishii N, Inoue Y, Sasaki T, Morita H, Ito H.

HeartRhythm Case Rep. 2018 Jun 30;4(10):444-446. doi: 10.1016/j.hrcr.2018.06.009. eCollection 2018 Oct. No abstract available.

9.

Progression of electrocardiographic abnormalities associated with initial ventricular fibrillation in asymptomatic patients with Brugada syndrome.

Morita H, Miyamoto M, Watanabe A, Tsukuda S, Morimoto Y, Kawada S, Nakagawa K, Nishii N, Ito H.

Heart Rhythm. 2018 Oct;15(10):1468-1474. doi: 10.1016/j.hrthm.2018.06.035. Epub 2018 Jun 25.

PMID:
29953954
10.

Colloidal Zn(Te,Se)/ZnS Core/Shell Quantum Dots Exhibiting Narrow-Band and Green Photoluminescence.

Asano H, Tsukuda S, Kita M, Fujimoto S, Omata T.

ACS Omega. 2018 Jun 20;3(6):6703-6709. doi: 10.1021/acsomega.8b00612. eCollection 2018 Jun 30.

11.

A new strategy to identify hepatitis B virus entry inhibitors by AlphaScreen technology targeting the envelope-receptor interaction.

Saso W, Tsukuda S, Ohashi H, Fukano K, Morishita R, Matsunaga S, Ohki M, Ryo A, Park SY, Suzuki R, Aizaki H, Muramatsu M, Sureau C, Wakita T, Matano T, Watashi K.

Biochem Biophys Res Commun. 2018 Jun 22;501(2):374-379. doi: 10.1016/j.bbrc.2018.04.187. Epub 2018 May 11.

PMID:
29730285
12.

Chemical array system, a platform to identify novel hepatitis B virus entry inhibitors targeting sodium taurocholate cotransporting polypeptide.

Kaneko M, Futamura Y, Tsukuda S, Kondoh Y, Sekine T, Hirano H, Fukano K, Ohashi H, Saso W, Morishita R, Matsunaga S, Kawai F, Ryo A, Park SY, Suzuki R, Aizaki H, Ohtani N, Sureau C, Wakita T, Osada H, Watashi K.

Sci Rep. 2018 Feb 9;8(1):2769. doi: 10.1038/s41598-018-20987-w.

13.

The mobility of proton carriers in phosphate glasses depends on polymerization of the phosphate framework.

Yamaguchi T, Kataoka T, Tsukuda S, Ishiyama T, Nishii J, Yamashita T, Kawazoe H, Omata T.

Phys Chem Chem Phys. 2017 Nov 8;19(43):29669-29675. doi: 10.1039/c7cp05241c.

PMID:
29085935
14.

Formation of Amorphous H3Zr2Si2PO12 by Electrochemical Substitution of Sodium Ions in Na3Zr2Si2PO12 with Protons.

Tsukuda S, Miyake K, Yamaguchi T, Kita M, Ishiyama T, Nishii J, Yamashita T, Kawazoe H, Omata T.

Inorg Chem. 2017 Nov 20;56(22):13949-13954. doi: 10.1021/acs.inorgchem.7b02060. Epub 2017 Oct 30.

PMID:
29083885
15.

Differences in endothelial dysfunction induced by paroxysmal and persistent atrial fibrillation: Insights from restoration of sinus rhythm by catheter ablation.

Okawa K, Miyoshi T, Tsukuda S, Hara S, Matsuo N, Nishibe N, Sogo M, Okada T, Nosaka K, Sakane K, Doi M, Morita H, Ito H.

Int J Cardiol. 2017 Oct 1;244:180-185. doi: 10.1016/j.ijcard.2017.06.038. Epub 2017 Jun 19.

PMID:
28668398
16.

Persistent Bioresorbable Vascular Scaffold by Optical Coherence Tomography Imaging at 5 Years.

Moriyama N, Shishido K, Tobita K, Takada T, Ochiai T, Tsukuda S, Yamanaka F, Sugitatsu K, Mizuno S, Tanaka Y, Murakami M, Matsumi J, Takahashi S, Akasaka T, Saito S.

JACC Cardiovasc Interv. 2017 Jan 23;10(2):e11-e13. doi: 10.1016/j.jcin.2016.11.008. Epub 2016 Dec 28. No abstract available.

17.

Histological analysis of vasculopathy associated with pulmonary hypertension in combined pulmonary fibrosis and emphysema: comparison with idiopathic pulmonary fibrosis or emphysema alone.

Awano N, Inomata M, Ikushima S, Yamada D, Hotta M, Tsukuda S, Kumasaka T, Takemura T, Eishi Y.

Histopathology. 2017 May;70(6):896-905. doi: 10.1111/his.13153. Epub 2017 Feb 8.

PMID:
27992963
18.

Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity.

Shimura S, Watashi K, Fukano K, Peel M, Sluder A, Kawai F, Iwamoto M, Tsukuda S, Takeuchi JS, Miyake T, Sugiyama M, Ogasawara Y, Park SY, Tanaka Y, Kusuhara H, Mizokami M, Sureau C, Wakita T.

J Hepatol. 2017 Apr;66(4):685-692. doi: 10.1016/j.jhep.2016.11.009. Epub 2016 Nov 25.

PMID:
27890789
19.

Early initiation of eicosapentaenoic acid and statin treatment is associated with better clinical outcomes than statin alone in patients with acute coronary syndromes: 1-year outcomes of a randomized controlled study.

Nosaka K, Miyoshi T, Iwamoto M, Kajiya M, Okawa K, Tsukuda S, Yokohama F, Sogo M, Nishibe T, Matsuo N, Hirohata S, Ito H, Doi M.

Int J Cardiol. 2017 Feb 1;228:173-179. doi: 10.1016/j.ijcard.2016.11.105. Epub 2016 Nov 9.

20.

A new class of hepatitis B and D virus entry inhibitors, proanthocyanidin and its analogs, that directly act on the viral large surface proteins.

Tsukuda S, Watashi K, Hojima T, Isogawa M, Iwamoto M, Omagari K, Suzuki R, Aizaki H, Kojima S, Sugiyama M, Saito A, Tanaka Y, Mizokami M, Sureau C, Wakita T.

Hepatology. 2017 Apr;65(4):1104-1116. doi: 10.1002/hep.28952. Epub 2017 Jan 17.

PMID:
27863453
21.

Fungus-Derived Neoechinulin B as a Novel Antagonist of Liver X Receptor, Identified by Chemical Genetics Using a Hepatitis C Virus Cell Culture System.

Nakajima S, Watashi K, Ohashi H, Kamisuki S, Izaguirre-Carbonell J, Kwon AT, Suzuki H, Kataoka M, Tsukuda S, Okada M, Moi ML, Takeuchi T, Arita M, Suzuki R, Aizaki H, Kato T, Suzuki T, Hasegawa H, Takasaki T, Sugawara F, Wakita T.

J Virol. 2016 Sep 29;90(20):9058-74. doi: 10.1128/JVI.00856-16. Print 2016 Oct 15.

22.

Anti-hepatitis C Virus Natural Product from a Fungus, Penicillium herquei.

Nishikori S, Takemoto K, Kamisuki S, Nakajima S, Kuramochi K, Tsukuda S, Iwamoto M, Katayama Y, Suzuki T, Kobayashi S, Watashi K, Sugawara F.

J Nat Prod. 2016 Feb 26;79(2):442-6. doi: 10.1021/acs.jnatprod.5b00555. Epub 2016 Feb 5.

PMID:
26848504
23.

Corrigendum: Amino Acid Polymorphisms in Hepatitis C Virus Core Affect Infectious Virus Production and Major Histocompatibility Complex Class I Molecule Expression.

Tasaka-Fujita M, Sugiyama N, Kang W, Masaki T, Murayama A, Yamada N, Sugiyama R, Tsukuda S, Watashi K, Asahina Y, Sakamoto N, Wakita T, Shin EC, Kato T.

Sci Rep. 2015 Dec 16;5:17208. doi: 10.1038/srep17208. No abstract available.

24.

Novel anticancer agent, SQAP, binds to focal adhesion kinase and modulates its activity.

Izaguirre-Carbonell J, Kawakubo H, Murata H, Tanabe A, Takeuchi T, Kusayanagi T, Tsukuda S, Hirakawa T, Iwabata K, Kanai Y, Ohta K, Miura M, Sakaguchi K, Matsunaga S, Sahara H, Kamisuki S, Sugawara F.

Sci Rep. 2015 Oct 12;5:15136. doi: 10.1038/srep15136.

25.

Fabrication of Thermoresponsive Nanoactinia Tentacles by a Single Particle Nanofabrication Technique.

Omichi M, Marui H, Padalkar VS, Horio A, Tsukuda S, Sugimoto M, Seki S.

Langmuir. 2015 Oct 27;31(42):11692-700. doi: 10.1021/acs.langmuir.5b02962. Epub 2015 Oct 19.

PMID:
26442713
26.

A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide.

Kaneko M, Watashi K, Kamisuki S, Matsunaga H, Iwamoto M, Kawai F, Ohashi H, Tsukuda S, Shimura S, Suzuki R, Aizaki H, Sugiyama M, Park SY, Ito T, Ohtani N, Sugawara F, Tanaka Y, Mizokami M, Sureau C, Wakita T.

J Virol. 2015 Dec;89(23):11945-53. doi: 10.1128/JVI.01855-15. Epub 2015 Sep 16.

27.

Amino Acid Polymorphisms in Hepatitis C Virus Core Affect Infectious Virus Production and Major Histocompatibility Complex Class I Molecule Expression.

Tasaka-Fujita M, Sugiyama N, Kang W, Masaki T, Murayama A, Yamada N, Sugiyama R, Tsukuda S, Watashi K, Asahina Y, Sakamoto N, Wakita T, Shin EC, Kato T.

Sci Rep. 2015 Sep 14;5:13994. doi: 10.1038/srep13994. Erratum in: Sci Rep. 2015;5:17208. Masaski, Takahiro [corrected to Masaki, Takahiro].

28.

Ridaifen G, tamoxifen analog, is a potent anticancer drug working through a combinatorial association with multiple cellular factors.

Ikeda K, Kamisuki S, Uetake S, Mizusawa A, Ota N, Sasaki T, Tsukuda S, Kusayanagi T, Takakusagi Y, Morohashi K, Yamori T, Dan S, Shiina I, Sugawara F.

Bioorg Med Chem. 2015 Sep 15;23(18):6118-24. doi: 10.1016/j.bmc.2015.08.001. Epub 2015 Aug 5.

PMID:
26314924
29.

Dysregulation of retinoic acid receptor diminishes hepatocyte permissiveness to hepatitis B virus infection through modulation of sodium taurocholate cotransporting polypeptide (NTCP) expression.

Tsukuda S, Watashi K, Iwamoto M, Suzuki R, Aizaki H, Okada M, Sugiyama M, Kojima S, Tanaka Y, Mizokami M, Li J, Tong S, Wakita T.

J Biol Chem. 2015 Feb 27;290(9):5673-84. doi: 10.1074/jbc.M114.602540. Epub 2014 Dec 30.

30.

Remote ischemic preconditioning reduces contrast-induced acute kidney injury in patients with ST-elevation myocardial infarction: a randomized controlled trial.

Yamanaka T, Kawai Y, Miyoshi T, Mima T, Takagaki K, Tsukuda S, Kazatani Y, Nakamura K, Ito H.

Int J Cardiol. 2015 Jan 15;178:136-41. doi: 10.1016/j.ijcard.2014.10.135. Epub 2014 Oct 23.

PMID:
25464237
31.

Fabrication of enzyme-degradable and size-controlled protein nanowires using single particle nano-fabrication technique.

Omichi M, Asano A, Tsukuda S, Takano K, Sugimoto M, Saeki A, Sakamaki D, Onoda A, Hayashi T, Seki S.

Nat Commun. 2014 Apr 28;5:3718. doi: 10.1038/ncomms4718.

32.

Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP).

Watashi K, Sluder A, Daito T, Matsunaga S, Ryo A, Nagamori S, Iwamoto M, Nakajima S, Tsukuda S, Borroto-Esoda K, Sugiyama M, Tanaka Y, Kanai Y, Kusuhara H, Mizokami M, Wakita T.

Hepatology. 2014 May;59(5):1726-37. doi: 10.1002/hep.26982. Epub 2014 Apr 1.

33.

Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP.

Iwamoto M, Watashi K, Tsukuda S, Aly HH, Fukasawa M, Fujimoto A, Suzuki R, Aizaki H, Ito T, Koiwai O, Kusuhara H, Wakita T.

Biochem Biophys Res Commun. 2014 Jan 17;443(3):808-13. doi: 10.1016/j.bbrc.2013.12.052. Epub 2013 Dec 14.

34.

Specific inhibition of hepatitis C virus entry into host hepatocytes by fungi-derived sulochrin and its derivatives.

Nakajima S, Watashi K, Kamisuki S, Tsukuda S, Takemoto K, Matsuda M, Suzuki R, Aizaki H, Sugawara F, Wakita T.

Biochem Biophys Res Commun. 2013 Nov 1;440(4):515-20. doi: 10.1016/j.bbrc.2013.09.100. Epub 2013 Oct 5.

PMID:
24099774
35.

Ridaifen B, a tamoxifen derivative, directly binds to Grb10 interacting GYF protein 2.

Tsukuda S, Kusayanagi T, Umeda E, Watanabe C, Tosaki YT, Kamisuki S, Takeuchi T, Takakusagi Y, Shiina I, Sugawara F.

Bioorg Med Chem. 2013 Jan 1;21(1):311-20. doi: 10.1016/j.bmc.2012.10.037. Epub 2012 Oct 29.

PMID:
23199482
36.

The antitumor agent doxorubicin binds to Fanconi anemia group F protein.

Kusayanagi T, Tsukuda S, Shimura S, Manita D, Iwakiri K, Kamisuki S, Takakusagi Y, Takeuchi T, Kuramochi K, Nakazaki A, Sakaguchi K, Kobayashi S, Sugawara F.

Bioorg Med Chem. 2012 Nov 1;20(21):6248-55. doi: 10.1016/j.bmc.2012.09.015. Epub 2012 Sep 16.

PMID:
23026082
37.

Semiconducting cross-linked polymer nanowires prepared by high-energy single-particle track reactions.

Seki S, Saeki A, Choi W, Maeyoshi Y, Omichi M, Asano A, Enomoto K, Vijayakumar C, Sugimoto M, Tsukuda S, Tanaka S.

J Phys Chem B. 2012 Oct 25;116(42):12857-63. doi: 10.1021/jp3069249. Epub 2012 Oct 11.

PMID:
23025696
38.

Temperature-responsive one-dimensional nanogels formed by the cross-linker-aided single particle nanofabrication technique.

Omichi M, Marui H, Takano K, Tsukuda S, Sugimoto M, Kuwabata S, Seki S.

ACS Appl Mater Interfaces. 2012 Oct 24;4(10):5492-7. doi: 10.1021/am3014086. Epub 2012 Sep 26.

PMID:
22971000
39.

Fullerene nanowires as a versatile platform for organic electronics.

Maeyoshi Y, Saeki A, Suwa S, Omichi M, Marui H, Asano A, Tsukuda S, Sugimoto M, Kishimura A, Kataoka K, Seki S.

Sci Rep. 2012;2:600. doi: 10.1038/srep00600. Epub 2012 Aug 24.

40.

Exploration of the binding proteins of perfluorooctane sulfonate by a T7 phage display screen.

Miyano Y, Tsukuda S, Sakimoto I, Takeuchi R, Shimura S, Takahashi N, Kusayanagi T, Takakusagi Y, Okado M, Matsumoto Y, Takakusagi K, Takeuchi T, Kamisuki S, Nakazaki A, Ohta K, Miura M, Kuramochi K, Mizushina Y, Kobayashi S, Sugawara F, Sakaguchi K.

Bioorg Med Chem. 2012 Jul 1;20(13):3985-90. doi: 10.1016/j.bmc.2012.05.016. Epub 2012 May 15.

PMID:
22658539
41.

Camptothecin (CPT) directly binds to human heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) and inhibits the hnRNP A1/topoisomerase I interaction.

Manita D, Toba Y, Takakusagi Y, Matsumoto Y, Kusayanagi T, Takakusagi K, Tsukuda S, Takada K, Kanai Y, Kamisuki S, Sakaguchi K, Sugawara F.

Bioorg Med Chem. 2011 Dec 15;19(24):7690-7. doi: 10.1016/j.bmc.2011.09.059. Epub 2011 Oct 5.

PMID:
22071521
42.

Screening of a library of T7 phage-displayed peptides identifies alphaC helix in 14-3-3 protein as a CBP501-binding site.

Matsumoto Y, Shindo Y, Takakusagi Y, Takakusagi K, Tsukuda S, Kusayanagi T, Sato H, Kawabe T, Sugawara F, Sakaguchi K.

Bioorg Med Chem. 2011 Dec 1;19(23):7049-56. doi: 10.1016/j.bmc.2011.10.004. Epub 2011 Oct 7.

PMID:
22032894
43.

A screening of a library of T7 phage-displayed peptide identifies E2F-4 as an etoposide-binding protein.

Takami M, Takakusagi Y, Kuramochi K, Tsukuda S, Aoki S, Morohashi K, Ohta K, Kobayashi S, Sakaguchi K, Sugawara F.

Molecules. 2011 May 24;16(5):4278-94. doi: 10.3390/molecules16054278.

44.

Customized morphologies of self-condensed multisegment polymer nanowires.

Tsukuda S, Seki S, Sugimoto M, Tagawa S.

J Phys Chem B. 2006 Oct 5;110(39):19319-22.

PMID:
17004787
45.

Self-condensed nanoparticles of oligofluorenes with water-soluble side chains.

Koizumi Y, Seki S, Tsukuda S, Sakamoto S, Tagawa S.

J Am Chem Soc. 2006 Jul 19;128(28):9036-7.

PMID:
16834368
46.

Radiologists in the IT era: the Saitama experience.

Tsukuda S, Inoue K, Heshiki A.

Biomed Imaging Interv J. 2006 Jul;2(3):e41. doi: 10.2349/biij.2.3.e41. Epub 2006 Jul 1.

47.
48.

Chronic expanding hematoma in the retroperitoneal space: a case report.

Irisawa M, Tsukuda S, Amanuma M, Heshiki A, Kuroda I, Ogawa F, Kayano H.

Radiat Med. 2005 Mar;23(2):116-20.

PMID:
15827529
49.

[Feasibility of CT attenuation values in the diagnosis of anemia].

Sato Y, Kozawa E, Tsukuda S, Amanuma M.

Nihon Igaku Hoshasen Gakkai Zasshi. 2004 Sep;64(7):394-7. Japanese.

PMID:
15688745
50.

Supplemental Content

Loading ...
Support Center